Brokerages expect Ceridian HCM Holding Inc (NYSE:CDAY) to announce $0.08 earnings per share (EPS) for the current fiscal quarter, according to Zacks Investment Research. Seven analysts have issued estimates for Ceridian HCM’s earnings, with estimates ranging from $0.05 to $0.12. The business is expected to report its next earnings report on Monday, February 4th.
According to Zacks, analysts expect that Ceridian HCM will report full-year earnings of ($0.09) per share for the current financial year, with EPS estimates ranging from ($0.14) to ($0.01). For the next fiscal year, analysts forecast that the firm will post earnings of $0.46 per share, with EPS estimates ranging from $0.43 to $0.49. Zacks’ earnings per share averages are an average based on a survey of research firms that that provide coverage for Ceridian HCM.
Ceridian HCM (NYSE:CDAY) last announced its earnings results on Monday, October 29th. The company reported $0.05 EPS for the quarter, topping the consensus estimate of $0.02 by $0.03. The business had revenue of $179.60 million during the quarter, compared to the consensus estimate of $176.29 million. Ceridian HCM had a negative net margin of 2.25% and a positive return on equity of 2.64%. The business’s revenue was up 9.8% compared to the same quarter last year.
In other Ceridian HCM news, COO Paul D. Elliott sold 197,816 shares of the business’s stock in a transaction dated Thursday, January 10th. The shares were sold at an average price of $36.00, for a total value of $7,121,376.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Cannae Holdings, Inc. sold 4,396,694 shares of the business’s stock in a transaction dated Friday, November 16th. The shares were sold at an average price of $34.70, for a total transaction of $152,565,281.80. The disclosure for this sale can be found here. Insiders sold a total of 5,181,103 shares of company stock valued at $182,511,844 in the last three months.
Hedge funds and other institutional investors have recently bought and sold shares of the business. State of Alaska Department of Revenue boosted its holdings in Ceridian HCM by 49.7% in the 4th quarter. State of Alaska Department of Revenue now owns 4,329 shares of the company’s stock valued at $149,000 after purchasing an additional 1,437 shares during the period. Voya Investment Management LLC bought a new stake in shares of Ceridian HCM during the 2nd quarter worth approximately $247,000. Public Employees Retirement System of Ohio bought a new stake in shares of Ceridian HCM during the 2nd quarter worth approximately $286,000. Point72 Asset Management L.P. bought a new stake in shares of Ceridian HCM during the 2nd quarter worth approximately $332,000. Finally, Cubist Systematic Strategies LLC bought a new stake in shares of Ceridian HCM during the 2nd quarter worth approximately $344,000. 72.21% of the stock is owned by hedge funds and other institutional investors.
Shares of CDAY stock opened at $35.95 on Wednesday. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.03 and a current ratio of 1.03. Ceridian HCM has a 52 week low of $28.65 and a 52 week high of $44.98.
Ceridian HCM Company Profile
Ceridian HCM Holding Inc operates as a human capital management (HCM) software company worldwide. The company offers Dayforce, a cloud HCM platform that address various areas of HCM, including human resources (HR), payroll, benefits, workforce management, and talent management functionality. It also provides Powerpay, a cloud platform, which offers scalable and straightforward payroll and HR solutions; Bureau solutions for payroll and payroll-related services; and LifeWorks, an employee engagement platform that delivers employee assistance programs, social recognition, perks and discounts, a private social network, employee and corporate wellness programs, and employee engagement analytics.
Featured Story: Terms to Better Understand Call Options
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Ceridian HCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceridian HCM and related companies with MarketBeat.com's FREE daily email newsletter.